Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review

被引:3
|
作者
Lai, Kuan-Chang [2 ]
Hsiao, Yi-Han [1 ]
Chen, San-Chi [3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Ctr Immunooncol, Dept Oncol, Div Med Oncol, Taipei, Taiwan
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
Pulse corticosteroid therapy; steroid-refractory; immune checkpoint inhibitors; pneumonitis; immune-related adverse event; nivolumab;
D O I
10.3389/fimmu.2022.994064
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune checkpoint inhibitors (ICIs) have demonstrated promising therapeutic outcomes in treating a variety of malignancies, but immune-related adverse events (irAE) may develop. Among all the irAE, immune-related pneumonitis was relatively common and life-threatening. High-dose corticosteroid was recommended for the initial management, but a part of patients developed steroid-refractory pneumonitis. Other immunosuppressants were recommended, but the optimal treatment is still controversial. Here, we report two cases of steroid-refractory immune-related pneumonitis who were successfully treated with pulse corticosteroid therapy. Case 1 was hepatocellular carcinoma treated with nivolumab for 5 months. She developed acute respiratory distress syndrome due to grade 4 immune-related pneumonitis that was refractory to intravenous methylprednisolone 2 mg/kg/day treatment. Methylprednisolone 500 mg for 3 days followed by 2 mg/kg/day steroid as maintenance therapy was given. Subsequently, her pneumonitis was regressed, and the endotracheal tube was successfully removed on day 9 after the start of pulse therapy. Case 2 presented with grade 4 immune-related pneumonitis in spite the use of methylprednisolone 1 mg/kg for his skin rash. Pulse corticosteroid therapy was prescribed, then his pneumonitis was completely regressed on day 12. In this report, we demonstrated the potential role of pulse corticosteroid therapy for steroid-refractory pneumonitis.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
    Beattie, Jason
    Rizvi, Hira
    Fuentes, Paige
    Luo, Jia
    Schoenfeld, Adam
    Lin, I-Hsin
    Postow, Michael
    Callahan, Margaret
    Voss, Martin H.
    Shah, Neil J.
    Warner, Allison Betof
    Chawla, Mohit
    Hellmann, Matthew D.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [22] Late-onset immune checkpoint inhibitor-related pneumonitis after cessation of sintilimab: A case report and literature review
    Wu, Yupei
    Yin, Yuesong
    Yan, Xiaolu
    Fang, Lingzhi
    Sun, Jiewei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (02)
  • [23] Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib
    Xing, Qian
    Zhang, Zhongwei
    Zhu, Biao
    Lin, Qionghua
    Shen, Lihua
    Li, Fangfang
    Xia, Zhili
    Zhao, Zhiyong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Successful Treatment of Steroid-Refractory Immune Thrombocytopenia in a Patient Developing Multiple Myeloma While on Immune Checkpoint Inhibitor Therapy for Lung Cancer: A Case Report
    Hayashi, Yudai
    Tsukada, Masao
    Shinoda, Daisuke
    Matsui, Marina
    Iwama, Kanichi
    Kajiwara, Koichi
    Yasuji, Kozai
    JOURNAL OF BLOOD MEDICINE, 2024, 15 : 285 - 290
  • [25] Success and failure of additional immunosuppressants in steroid-refractory pneumonitis related to immune checkpoint blockade.
    Beattie, Jason
    Fuentes, Paige
    Rizvi, Hira
    Luo, Jia
    Schoenfeld, Adam Jacob
    Postow, Michael A.
    Callahan, Margaret K.
    Warner, Allison Betof
    Chawla, Mohit
    Hellmann, Matthew David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
    Poulose, Vijo
    CHEST, 2022, 161 (03) : E196 - E197
  • [27] The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis
    Asada, Mizuho
    Mikami, Takahisa
    Niimura, Takahiro
    Zamami, Yoshito
    Uesawa, Yoshihiro
    Chuma, Masayuki
    Ishizawa, Keisuke
    ONCOLOGY, 2021, 99 (04) : 256 - 259
  • [29] Steroid-Refractory Immune Checkpoint Inhibitor-Associated Myocarditis
    Zlotoff, Daniel A.
    Cohen, Justine V.
    Zubiri, Leyre
    Pereira, Debra
    Hung, Yin P.
    Stone, James R.
    Kormos, William A.
    Neilan, Tomas G.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S125 - S125
  • [30] Predictors of steroid-refractory immune checkpoint inhibitor associated myocarditis
    Power, J.
    Meijers, W.
    Fenioux, C.
    Tamura, Y.
    Asnani, A.
    Alexandre, J.
    Cautela, J.
    Aras, M.
    Lehmann, L.
    Perl, M.
    Narezkina, A.
    Gilstrap, L.
    Ederhy, S.
    Moslehi, J.
    Salem, J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3272 - 3272